PAA 4.88% 21.5¢ pharmaust limited

Covi-Pantel . NZ Trader Release, page-1082

  1. 12,272 Posts.
    lightbulb Created with Sketch. 6280
    The Company can not sit on Material information, anything that has the ability to effect the SP must be disclosed immediately ..

    Looking forward to tomorrow ,,,,, well done to the RAC holders , Oncology done well ,,, 4.5c to $2.65 shows what can be achieved ... text book gains from promoting Scientific Progress...

    PAA may have to make a statement as the Leiden data was promoted to be delivered December 2019 now heading into mid February? surely they must have a heads up on a timeline?? these are scientific trials ,,what has been achieved to date? sure it may not be complete but is the current work promising ?? If longer delays are expected maybe move the research to Monash University where another ASX Biotech is having a Tablet tested currently? or back to WEHI? or Biolabs 360....??




 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.